Updated: March 22, 2021

Listed here are opportunities available to CBC researchers through CBC-supported efforts as well as through CBC-independent initiatives.


CBC-Supported Opportunities

Chicago Synthetic Antibody Pipeline (CSAP)

Due to a CBC Lever Award, CBC researchers have special access to this powerful technology:


Other Opportunities

Posted: March 22, 2021
2021 Bioscience Startup Business Plan Competition (BPC)
Rosalind Franklin University of Medicine and Science and Smarthealth Activator invites you to register and participate in the 2021 Business Plan Competition. Open to Bioscience startups: diagnostics, therapeutics, medical devices, digital healthcare, and healthcare services (students, faculty, entrepreneurs). Each team is required to fill out and submit a registration form. Registration deadline is March 30, 2021.
▸ Learn more

Posted: December 21, 2020
New Funding Opportunity
Cures Within Reach is excited to announce our new funding opportunity Request for Proposals (RFP), with up to $50,000 available for clinical repurposing trials impacting veterans in any disease area, including mental health, PTSD and brain injury. Clinical repurposing trials from any US-based institution impacting veterans are eligible. Proposal submissions due February 26, 2021.
▸ Read more

Posted: March 23, 2020
HHMI Opens New Program for Medically Trained Scientists
HHMI’s Medically Trained Scientists Program (MTS) seeks early career scientists with knowledge of human biology to move discovery science forward. MTS will ultimately invest up to $120 million in up to 40 fellows. MTS fellows are creative and highly committed individuals whose research will impact significant biological problems. Fellows are committed to careers in academic research and will receive long-term support as they transition through mentored postdoctoral training to independent faculty. Application due date
August 11, 2020, 3:00 p.m. (ET).

▸ Learn more

Posted: January 31, 2020 I Updated: March 16, 2020
Cures Within Reach Funding Opportunities
Cures Within Reach has several new funding opportunity Requests for Proposals including those available to faculty members at the CBC universities:

  • Up to $100,000 for clinical and up to $50,000 for preclinical repurposing research in Meniere’s disease (proposals due April 3, 2020)
  • Up to $50,000 for clinical repurposing research in rare blood cancers (proposals due April 3, 2020)
  • Up to $50,000 for clinical repurposing research in retinitis pigmentosa (proposals due April 3, 2020)
  • Up to $50,000 for repurposing research based in the Chicagoland area (EXTENDED! Proposals now due June 15, 2020)

▸ Flyer
▸ Learn more and apply

Posted: January 9, 2020
14th Annual Drug Discovery for Neurodegeneration Workshop:
A Course on Translating Research into Novel Drug Targets

Organizer: Alzheimer’s Drug Discovery Foundation (ADDF)
Date: April 26-28, 2020
Location: Sonesta Philadelphia Downtown Rittenhouse Square, Philadelphia
This interactive workshop is designed as an introductory course covering all aspects of drug discovery for neurodegenerative diseases, including Alzheimer’s, Parkinson’s, Huntington’s disease, Amyotrophic Lateral Sclerosis, Frontotemporal Degeneration, and Multiple Sclerosis.
▸ Learn more
▸ 2020 ADDF Young Investigator Travel Scholarships and Awards

Posted: December 4, 2019
MedTech Innovator – RFA
MedTech Innovator, the medtech industry’s global competition and accelerator is looking for outstanding early- to mid-stage medical device, diagnostic, and digital health companies who are transforming healthcare. Companies selected for the program will receive $500,000 in non-dilutive cash prizes and a complimentary full-access registration and a presentation slot at two premier conferences: the WSGR Medical Device Conference in San Francisco and The MedTech Conference powered by AdvaMed in Toronto.
▸ Learn more

Posted: December 3, 2019
The Spinoff Prize
The Spinoff Prize has been established by Nature Research in partnership with Merck KGaA to showcase and celebrate global excellence in the commercialisation of research through the creation of spinoff companies.
▸ Learn more

Posted: December 3, 2019
AIMS Awards
Support for researchers at universities, hospitals, and other academic research institutions around the world to discover new drugs.
▸ Learn more

Posted: October 4, 2019 (Updated: January 7, 2020)
Keystone Symposium — The Brain Therapeutics: Disruptive Technologies and Opportunities
Date: February 16—19, 2020
Location: Eldorado Hotel & Spa, Santa Fe, New Mexico

Speakers include Jim Audia, former CBC Executive Director, who will present: “Drug Discovery in the Academic and Not-For-Profit Community”

Attention students and post-doctoral fellows: the KS scholarship deadline is fast approaching (Oct. 15!). Not only are KS Scholarships prestigious, but they also provide up-and-coming scientists with invaluable networking and career-development opportunities to advance their research, and careers. Awardees will present their work alongside field leaders, and be introduced to scientific and technological frontiers to inspire new, fruitful research directions and collaborations.
▸ Learn more

Posted: September 19, 2019
Tau2020 Global Conference
Date: February 12-13, 2020
Location: Marriott Marquis Washington, D.C.

In partnership with CurePSP and the Alzheimer’s Association, the Rainwater Foundation is a proud organizing sponsor of the Tau2020 Global Conference. The conference is open to anyone with an interest in research about the causes and treatments for tau-related diseases. Representatives from academia, industry, government, and the philanthropic/advocacy sector are encouraged to attend.
▸ Learn more

Posted: September 10, 2019
Funding Opportunity – The Tau Pipeline Enabling Program (T-PEP)

The Tau Pipeline Enabling Program (T-PEP) seeks to accelerate the discovery of potential new therapies for tauopathies. The intent of this program is to enrich the pipeline for therapy development by facilitating the translation of academia derived ideas into practical application. In short, it bridges the gap between innovative but resource-constrained researchers and the larger pharmaceutical companies that are looking for drug candidates to be taken into human trials.

The overarching goal of T-PEP is to promote the advanced study of a wide range of novel targets, agents and/or therapeutic strategies that will accelerate the development of disease modifying interventions for tauopathies.

T-PEP is open to researchers at academic institutions as well as small companies. There is no strict cut-off for company size, but preference will be given to companies with 50 or fewer employees.The maximum grant amount is $750,000. Non-profit academic institutions are allowed up to 10% indirect costs; no indirect costs are allowable for for-profit companies. The maximum project duration is 2 years, and there is no minimum time frame. As co-sponsors of the grant program, the Alzheimer’s Association and the Tau Consortium will jointly monitor progress toward project milestones; continued disbursement of funds may be made contingent on demonstrated progress toward key milestones.

LOI Deadline: September 12, 2019, 5:00 PM ET
LOI is now open: https://proposalcentral.com/GrantOpportunities.asp
▸ Learn more

Posted: September 10, 2019
Lakeside Discovery and West Loop Innovations announce Fall 2019 RFP

The timeline for the submission cycle is identical for both Lakeside Discovery and West Loop Innovations. RFP opened September 3, 2019; LOIs submissions deadline October 9, 2019.
▸ Learn more

Posted: August 19, 2019
Job Opportunity: ClostraBio is seeking talented people!

ClostraBio is looking for a Scientific Operations Manager to drive the ongoing development of ClostraBio’s microbiome-modulating technologies. ClostraBio is a preclinical stage company creating new medicines to prevent and treat food allergy. These medicines work by altering the microbiome – the trillions of bacteria, viruses, fungi, and related compounds – that live in the human gut. Founded in 2016 based on groundbreaking work from the University of Chicago, the company has raised $4.6M to date and now supports 4 employees through a sponsored research agreement with the University of Chicago.

▸ Learn more

Posted: August 8, 2018
New, Updated and Expanded Services provided by the University of Chicago Genomics Facility

The University of Chicago Genomics Facility has:

Posted: August 1, 2018
New Opportunities for the CBC Community

Northwestern’s NSF-Simons Center for Quantitative Biology has a few opportunities for researchers in quantitative biology.

Posted: October 27, 2015
University of Chicago Graham School Launches Master of Science Degree in Biomedical Informatics

Biomedical informatics, one of the world’s fastest-growing interdisciplinary fields, is the latest graduate degree program offered by the University of Chicago Graham School of Continuing Liberal and Professional Studies. The University brings together its esteemed faculty and programs in genomic research, translational medicine, and computation within the new Master of Science Degree in Biomedical Informatics (MScBMI).

▸ Press Release, October 27, 2015 (PDF)
▸ Program website

Posted: March 30, 2015
Globus Genomics for Core Labs

Globus Genomics is an end-to-end data management and large scale analysis service that addresses the challenges that researchers face when dealing with NGS analysis on a large scale. It combines state-of-the-art algorithms with sophisticated data management tools, a powerful graphical workflow environment, and a cloud-based elastic computational infrastructure. Globus Genomics is software-as-a-service, delivered as a monthly subscription with the appropriate level of resources to meet your specific needs. Globus Genomics is being used by over a dozen informatics cores, research groups at various universities. For a limited period, we are offering Globus Genomics for free for a month to qualified researchers in the CBC. Please contact Ravi Madduri or Paul Dave for more information.

▸ Program website
▸ Download flyer (PDF)